Stryker Corporation (VIE:SYK)
Austria · Delayed Price · Currency is EUR | Market Cap | 106.06B -17.7% |
| Revenue (ttm) | 21.92B +8.8% |
| Net Income | 2.89B +16.7% |
| EPS | 7.49 +16.8% |
| Shares Out | n/a |
| PE Ratio | 36.65 |
| Forward PE | 19.97 |
| Dividend | 3.00 (1.08%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | n/a |
| Open | 282.80 |
| Previous Close | 289.70 |
| Day's Range | 282.80 - 282.80 |
| 52-Week Range | 239.30 - 353.60 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 30, 2026 |
About Stryker
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally inv... [Read more]
Financial Performance
In 2025, Stryker's revenue was $25.12 billion, an increase of 11.16% compared to the previous year's $22.60 billion. Earnings were $3.25 billion, an increase of 8.45%.
Financial numbers in USD Financial StatementsNews
Stryker announces U.S. commercial launch of Mako RPS
Stryke announced the U.S. commercial launch of Mako RPS for total knee replacement procedures, further expanding the Mako portfolio into a new category of orthopaedic robotics. The launch marks the…
Stryker expands Mako robotics portfolio with full market release of Mako RPS
New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic market Stryker announced the U.S. commercial launch of M...
Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings
Booking Holdings, Alphabet, and six other companies have underperformed their sectors despite improving earnings expectations, setting up potential upside during second-quarter earnings season.
Stryker price target lowered to $371 from $379 at BTIG
BTIG lowered the firm’s price target on Stryker (SYK) to $371 from $379 and keeps a Buy rating on the shares as part of a broader research note previewing Q2…
Stryker price target raised to $370 from $350 at Argus
Argus raised the firm’s price target on Stryker (SYK) to $370 from $350 and keeps a Buy rating on the shares. The firm is confident that the company will be…
Stryker initiated with an Outperform at BMO Capital
BMO Capital initiated coverage of Stryker (SYK) with an Outperform rating and $369 price target The March 2026 cyberattack was an operational disruption, not a demand story, and hospital order…
Buy these quality, low-stress stocks for the summer, says Jefferies
Markets have become more volatile as investors debate whether big tech companies are getting enough return on their AI spending. The S&P 500 momentum index has outperformed the wider market by more th...
Stryker price target lowered to $350 from $355 at Evercore ISI
Evercore ISI lowered the firm’s price target on Stryker (SYK) to $350 from $355 and keeps an Outperform rating on the shares. The firm’s Q2 preview for MedTech, Life Sciences…
Stryker to announce second quarter 2026 financial results
Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial result...
Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
PORTAGE, Mich., June 24, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, today announced a new partnership with Major Champion and globally recognized golfer Shane L...
Stryker price target lowered to $380 from $450 at BofA
BofA lowered the firm’s price target on Stryker (SYK) to $380 from $450 and keeps a Buy rating on the shares. Noting that the firm’s services team continues to highlight…
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
PORTAGE, Mich., June 2, 2026 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support perfo...
Stryker announces European launch of Pangea Plating System
Stryker (SYK) announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns. Prof. Alex Trompeter, design surgeon and…
Stryker Launches Pangea Plating System and Completes First Case in Europe
AMSTERDAM--(BUSINESS WIRE)--Stryker announced the European launch of its Pangea Plating System, a plating platform for the treatment of a wide range of fracture patterns.
BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem
CHARLEVOIX, Mich.--(BUSINESS WIRE)--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (A...
AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study
BOSTON--(BUSINESS WIRE)--Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enroll...
Stryker Transcript: Bank of America Global Healthcare Conference 2026
Leadership reaffirmed commitment to innovation and M&A, with strong recovery plans after a cyber incident. Full-year guidance is maintained, supported by robust demand, operational resilience, and a healthy capital backlog. Mako robotics and new product launches drive growth.
Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology com...
Stryker declares an $0.88 per share quarterly dividend
Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders...
Stryker Transcript: AGM 2026
The meeting confirmed strong double-digit sales growth, major acquisitions, and a continued focus on innovation. All board nominees, auditor ratification, and executive compensation were approved. The five-year outlook projects sustained high growth through innovation and acquisitions.
Stryker price target lowered to $330 from $380 at Truist
Truist analyst Richard Newitter lowered the firm’s price target on Stryker (SYK) to $330 from $380 and keeps a Hold rating on the shares. The firm is adjusting its model…
Stryker price target lowered to $394 from $469 at Barclays
Barclays analyst Matt Miksic lowered the firm’s price target on Stryker (SYK) to $394 from $469 and keeps an Overweight rating on the shares. The company’s Q1 results were mixed…
Stryker price target raised to $361 from $357 at Goldman Sachs
Goldman Sachs analyst David Roman raised the firm’s price target on Stryker (SYK) to $361 from $357 and keeps a Neutral rating on the shares after its Q1 earnings. The…
Stryker price target lowered to $385 from $437 at Baird
Baird lowered the firm’s price target on Stryker (SYK) to $385 from $437 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results where…
Stryker price target lowered to $410 from $465 at Bernstein
Bernstein lowered the firm’s price target on Stryker (SYK) to $410 from $465 and keeps an Outperform rating on the shares. The firm notes that given Q1 disruption that was…